KR20090129686A - Composition for the fried food containing cassia tora l. mixed extracts and method for preparing the same - Google Patents
Composition for the fried food containing cassia tora l. mixed extracts and method for preparing the same Download PDFInfo
- Publication number
- KR20090129686A KR20090129686A KR1020080055733A KR20080055733A KR20090129686A KR 20090129686 A KR20090129686 A KR 20090129686A KR 1020080055733 A KR1020080055733 A KR 1020080055733A KR 20080055733 A KR20080055733 A KR 20080055733A KR 20090129686 A KR20090129686 A KR 20090129686A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- frying
- extract
- powder
- composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 122
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 235000013305 food Nutrition 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 18
- 244000201986 Cassia tora Species 0.000 title abstract description 12
- 235000014552 Cassia tora Nutrition 0.000 title abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 45
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 29
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 29
- 240000008042 Zea mays Species 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 41
- 210000004369 blood Anatomy 0.000 claims description 23
- 239000008280 blood Substances 0.000 claims description 23
- 210000004185 liver Anatomy 0.000 claims description 23
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 19
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 19
- 235000005822 corn Nutrition 0.000 claims description 19
- 235000013312 flour Nutrition 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 15
- 230000003078 antioxidant effect Effects 0.000 claims description 14
- 235000012000 cholesterol Nutrition 0.000 claims description 13
- 240000005856 Lyophyllum decastes Species 0.000 claims description 12
- 235000013194 Lyophyllum decastes Nutrition 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 8
- 230000004224 protection Effects 0.000 claims description 8
- 241000209140 Triticum Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 6
- 235000013339 cereals Nutrition 0.000 claims description 5
- 244000144725 Amygdalus communis Species 0.000 claims description 4
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 4
- 240000004160 Capsicum annuum Species 0.000 claims description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 4
- 235000007862 Capsicum baccatum Nutrition 0.000 claims description 4
- 240000003183 Manihot esculenta Species 0.000 claims description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000020224 almond Nutrition 0.000 claims description 4
- 239000001728 capsicum frutescens Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 229940029982 garlic powder Drugs 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 3
- 102000002322 Egg Proteins Human genes 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 3
- 244000203593 Piper nigrum Species 0.000 claims description 3
- 235000008184 Piper nigrum Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 235000013614 black pepper Nutrition 0.000 claims description 3
- 235000014103 egg white Nutrition 0.000 claims description 3
- 210000000969 egg white Anatomy 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 230000002440 hepatic effect Effects 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 238000003860 storage Methods 0.000 abstract description 32
- 235000019640 taste Nutrition 0.000 abstract description 11
- 235000007244 Zea mays Nutrition 0.000 abstract description 5
- 229940089639 cornsilk Drugs 0.000 abstract description 4
- 239000001231 zea mays silk Substances 0.000 abstract description 4
- 238000004108 freeze drying Methods 0.000 abstract 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 44
- 230000000694 effects Effects 0.000 description 28
- 238000012360 testing method Methods 0.000 description 25
- 206010012601 diabetes mellitus Diseases 0.000 description 19
- 150000002632 lipids Chemical class 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 17
- 230000001953 sensory effect Effects 0.000 description 17
- 235000005911 diet Nutrition 0.000 description 16
- -1 liver protection Substances 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000003925 fat Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 210000005228 liver tissue Anatomy 0.000 description 8
- 150000002978 peroxides Chemical class 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 235000018823 dietary intake Nutrition 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 235000019786 weight gain Nutrition 0.000 description 6
- 230000004584 weight gain Effects 0.000 description 6
- 102000016938 Catalase Human genes 0.000 description 5
- 108010053835 Catalase Proteins 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 235000019629 palatability Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Natural products OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- KVJHGPAAOUGYJX-UHFFFAOYSA-N 1,1,3,3-tetraethoxypropane Chemical compound CCOC(OCC)CC(OCC)OCC KVJHGPAAOUGYJX-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 241001325860 Lacanobia oleracea Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical group C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000000871 hypocholesterolemic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000013222 sprague-dawley male rat Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- JIBJMBHKGBDCPN-IJTBWITGSA-N 5-hydroxy-8-methoxy-2-methyl-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxybenzo[g]chromen-4-one Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC=1C=C(C=C2C=C3C(C(C=C(C)O3)=O)=C(O)C2=1)OC)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JIBJMBHKGBDCPN-IJTBWITGSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- PAIOZXJXGSOKFN-UHFFFAOYSA-N Aceric acid Natural products CC1OC(O)C(O)C1(O)C(O)=O PAIOZXJXGSOKFN-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000024671 Brassica kaber Species 0.000 description 1
- 235000014750 Brassica kaber Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004452 decreased vision Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QNVRIHYSUZMSGM-UHFFFAOYSA-N n-butyl methyl carbinol Natural products CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 1
- ZOCHHNOQQHDWHG-UHFFFAOYSA-N n-hexan-3-ol Natural products CCCC(O)CC ZOCHHNOQQHDWHG-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 결명자 혼합 추출물을 함유한 튀김용 조성물에 관한 것으로, 보다 구체적으로는 볶은 결명자와 볶은 보리 및 옥수수 수염을 혼합하여 추출한 결명자 혼합 추출물의 항산화, 간장 보호, 혈당 강하 및 혈중 콜레스테롤 저하 활성을 이용한 튀김용 조성물 및 이로부터 제조된 저장안정성이 향상되고, 풍미 및 기호도가 우수한 튀김 식품에 관한 것이다.The present invention relates to a frying composition containing a mixed extract of the Clarifier, more specifically, using the antioxidant, liver protection, blood sugar lowering and blood cholesterol lowering activity of the Clarifier extract extracted by mixing the roasted barley and roasted barley and corn beard The composition for frying and the storage stability prepared therefrom are improved, and it relates to the fried food with excellent flavor and preference.
결명자(Cassia tora L.)는 콩과에 속하는 한해살이풀로써 성숙한 씨를 말린 것으로 달고, 쓰며, 짜고 성질은 약간 차고 독은 없으며 간과 대장에 작용한다. 간의 열기를 제거하고 대장의 연동운동을 활발히 하여 눈이 충혈되어 붓고 아프며 눈물이 흐르거나 시력감퇴, 야맹증, 두통, 고혈압, 혈중 콜레스테롤의 저하 등에 효과가 있는 것으로 알려져 있고, 주성분으로 크리소판올(chrysophanol), 이모 딘(emodin), 레인(rhein), 옵스투신(obstusin), 루보-푸사린 겐티오비오사이드(rubro-fusarin gentiobioside), 안트라퀴논 글리코사이드(anthraquinone glycosides) 등이 보고되고 있다. Cassia tora L.) is a perennial herb that belongs to the legumes and is dried, sweet, salty, salty, slightly cold, and nontoxic, acting on the liver and large intestine. It is known to be effective in removing the heat of the liver and activating the peristalsis of the large intestine, so that the eyes are red, swollen and painful, tears flow, decreased vision, night blindness, headache, high blood pressure, and lowered blood cholesterol.The main ingredient is chrysophanol. ), Emodin, rhein, obstusin, rubro-fusarin gentiobioside, anthraquinone glycosides and the like have been reported.
결명자의 효능에 관한 연구로서 혈압강하효과, 혈당강하효과, 자유 라디칼 소거작용 등이 보고되고 있다(Tae Youl Ha, Il Jin Cho, Ki Seung Seong, and Sang Hyo Lee. Effect of Cassia tora ethanol extract on the lipid levels of serum and liver in rats fed high cholesterol diet. J. Korean Soc. Food Sci. Nutr. 30(6) 1171-1176 (2001)). 결명자의 항산화효과에 관한 연구보고로는 결명자 추출물의 산화적 스트레스 억제효과, free radical 소거작용 등이 보고되어 있다((Gyung Min Na, Ho Suk Han, Su Hyang Ye, and Hyun Ku Kim. Extraction characteristics and antioxidative activity of Cassia tora L. extracts. Korean J. Food Culture 19(5) 499-505 (2004)).Blood pressure lowering effect, hypoglycemic effect, free radical scavenging effect, etc. have been reported as a study on the effect of the deficiency (Tae Youl Ha, Il Jin Cho, Ki Seung Seong, and Sang Hyo Lee.Effect of Cassia tora ethanol extract on the lipid levels of serum and liver in rats fed high cholesterol diet. J. Korean Soc. Food Sci. Nutr. 30 (6) 1171-1176 (2001). Studies on the antioxidant effects of the deficiency have been reported to inhibit the oxidative stress and free radical scavenging effect of the extract (Gyung Min Na, Ho Suk Han, Su Hyang Ye, and Hyun Ku Kim. antioxidative activity of Cassia tora L. extracts. Korean J. Food Culture 19 (5) 499-505 (2004).
그러나 결명자 추출물은 약한 고미와 함께 기호성이 높지 않은 냄새를 가지므로 이를 다른 잡곡 등의 천연물을 혼합하여 추출함으로써 고미를 완화하고 기호도를 향상시킬 수 있는 방법이 요구되고 있다. However, because the extract of the Cassiae has a weak taste and not a high palatability smell, there is a need for a method that can mitigate the taste and improve the palatability by extracting a mixture of natural products such as other grains.
한편 보리는 우리 식생활에서 쌀 다음으로 중요한 기본 식량으로써 사용 될 뿐만 아니라 맥아의 형태로는 식혜나 맥주를 만들 때 이용되고 있다. 또한 보리는 가루로 만들어져 밀가루 대체 복합분으로 이용되기도 한다(Barley as a food grain. Newman R.K. and Newman C.W., Cereal foods world. 36: 800-805(1991)). 보리는 특히 식이섬유로서 β-글루칸의 함량이 높아 체내 혈중콜레스테롤 수치를 저하시킴으로써 심장질환을 예방할 뿐만 아니라 체지방의 축적을 억제하여 비만에 수반되는 증상을 완화하는 등 성인병의 예방에 탁월한 효과가 있는 것으로 알려져 있다(Quality characteristics of barley β-glucan enriched noodles. Young-Tack Lee and Ji-Young Jung, Korean J. Food Sci Technol 35(3) 405-409(2003)). On the other hand, barley is not only used as the basic food after rice in our diet, but also in the form of malt to make food or beer. Barley is also made from flour and used as a flour substitute (Barley as a food grain.Newman R.K. and Newman C.W., Cereal foods world. 36: 800-805 (1991)). Barley is a dietary fiber with a high content of β-glucan, which lowers blood cholesterol levels in the body, which not only prevents heart disease, but also inhibits the accumulation of body fat, thereby relieving the symptoms associated with obesity. (Quality characteristics of barley β-glucan enriched noodles. Young-Tack Lee and Ji-Young Jung, Korean J. Food Sci Technol 35 (3) 405-409 (2003)).
옥수수수염은 우리나라뿐만 아니라 중국, 베트남 및 남미 등지에서도 특유의 약리효과가 있어 약용으로 널리 이용되는데 주로 신선하고 건조된 것이 이뇨제 및 당뇨병 치료제로 사용되고 있으며(Volatile components of cornsilk(Zea mays L.). Jae-Jin Kwag, Jae-Gon Lee, Hee-Jin Jang, Ok-Chan Kim. Korean J. FOOD & NUTR., 12(4): 375-379(1999)), 그 외에도 옥수수 수염은 식품 등의 향료 및 식품첨가물로도 활용되고 있는데 FEMA(Flavor and Extract Manufactures Association), FDA(Food and Drug Administration)에 의해 안전한 물질로 등재되어 있으며 주로 음료, 빙과류, 사탕, 제빵 등에 이용되는 것으로 알려져 있다(Furia T.E. and Bellanca N., Fenaloli's handbook of flavor ingredients. 2nd ed., CRC Press, Inc., Cleveland.1: 335(1975)). 그 성분으로는 포도당, 과당과 같은 유리당을 함유한다. 그리고 유기산으로서 피트산, 옥살산, 말산, 쉬킴산, 글루타르산 및 아세트산이 검출되며, 단백질 함량은 3.36-4.17% 정도이며, 향기성분으로는 아세트알데하이드, 에탄올, 아세톤, DMS, 이소-부틸알데하이드, 시스-3-헥산올, 3-헥소-1-올, 아세테이트, 트란스-2-헥산올, 펜탄올 등이 보고되고 있다(Physicochemical characteristics of corn silk. Sun-Lim Kim, Cheol- Ho Park, E-Hun Kim, Han-Sun Hur, and Young-Koo Son. Korean J. Crop Sci. 45(6):392-399(2000))Corn beard is widely used for medicinal purposes because of its unique pharmacological effect not only in Korea but also in China, Vietnam and South America. Fresh and dried is used as a diuretic and diabetes treatment (Volatile components of cornsilk ( Zea mays L.). Jin Kwag, Jae-Gon Lee, Hee-Jin Jang, Ok-Chan Kim.Korean J. FOOD & NUTR., 12 (4): 375-379 (1999)). It is also used as a food additive, and it is listed as a safe substance by the Flavor and Extract Manufacturers Association (FEMA) and the Food and Drug Administration (FDA), and it is known to be mainly used in beverages, ice cream, candy, and baking (Furia TE and Bellanca). N., Fenaloli's handbook of flavor ingredients.2nd ed., CRC Press, Inc., Cleveland. 335 (1975). Its components include free sugars such as glucose and fructose. In addition, phytic acid, oxalic acid, malic acid, succinic acid, glutaric acid and acetic acid are detected as organic acids, and the protein content is about 3.36-4.17%. As a fragrance component, acetaldehyde, ethanol, acetone, DMS, iso-butylaldehyde, Cis-3-hexanol, 3-hex-1-ol, acetate, trans-2-hexanol, pentanol and the like have been reported (Physicochemical characteristics of corn silk.Sun-Lim Kim, Cheol-ho Park, E- Hun Kim, Han-Sun Hur, and Young-Koo Son.Korean J. Crop Sci. 45 (6): 392-399 (2000))
종래 결명자를 이용한 식품 또는 음료를 제조하기 위해 다양한 기술이 개발된 바 있고, 대한민국 특허출원 제10-2000-0058539호 “결명자가 혼합된 보리차의 제조방법”에 이물질이 제거되고 깨끗이 세척된 보리와 결명자를 20℃ 이하의 물속에서 24시간과 2시간씩 각각 침지를 시킨 후 20℃ 온도에서 3일간 0.5~1mm로 발아를 시켜 이를 건조기에 넣고 60℃ 온도로 12시간 건조를 시킨다음 170℃ 온도에서 10~30분간 볶은 후 상온에서 냉각을 시켜 맥아 90% 결명자 10%의 혼합비율로 포장하여 제조하는 것을 특징으로 하는 결명자가 혼합된 보리차의 제조방법이 개시되어 있으며, 대한민국 특허출원 제10-2005-0026489호 “옥수수 수염 추출액을 함유한 음료의 제조방법”에 옥수수 수염의 건엽을 스티밍(steaming)하거나 또는 블랜칭(blanching)한 후 최적화된 추출 조건 하에서 옥수수 수염 추출액을 제조하고, 이를 여과한 다음, 산화방지제 및 부재료를 첨가한 후, 공기접촉과 혼입을 배제하기 위하여 질소액을 충진하고 살균 및 냉각하는 것을 특징으로 하는 옥수수 수염 추출액을 함유한 음료의 제조방법, 상기 방법으로 제조된 옥수수 수염 추출액을 함유한 음료 및 식품이 개시되어 있다. Various techniques have been developed to manufacture food or beverage using conventional deficiencies, and the barley and the deficiencies have been removed and the foreign substances are removed and cleaned in Korean Patent Application No. 10-2000-0058539 "Method of manufacturing barley tea mixed with deficiencies". After immersing in water at 20 ℃ or below for 24 hours and 2 hours respectively, germinate at 0.5 ~ 1mm for 3 days at 20 ℃, put it in a dryer, and dry it at 60 ℃ for 12 hours and then at 10 ℃ at 170 ℃. A method of preparing barley tea mixed with a defect is disclosed, which is prepared by roasting at a room temperature for about 30 minutes and then cooling the mixture at a mixture ratio of 90% maltose and maltose, and Korean Patent Application No. 10-2005-0026489 No. “Method for preparing a beverage containing corn mustard extract” under steam and / or blanching dried leaves of corn stubble under optimized extraction conditions. After preparing the sorghum beard extract, filtering it, adding antioxidant and subsidiary material, and then filling, sterilizing and cooling the nitrogen liquid to exclude air contact and incorporation, Disclosed are a preparation method, a beverage and a food containing the corn beard extract prepared by the above method.
하지만 결명자를 주성분으로 하고, 보리와 옥수수 수염을 부재료로 사용하여 제조된 혼합 추출물에 대해서는 개시된 바 없으며, 또한 이들 혼합 추출물의 생리 활성을 밝혀내려는 시도 또한 행하여진 바 없다. However, there is no disclosure about mixed extracts prepared using the resolver as a main ingredient and barley and corn whiskers as submaterials, and no attempt has been made to reveal the physiological activity of these mixed extracts.
닭고기 튀김은 동서양을 막론하고 세대에 관계없이 누구나 즐기는 간식 및 즉석식품으로 가장 애용되고 있는 것 중의 하나이다. 최근에는 닭고기 업체가 프랜차이즈화하면서 많은 업체가 서로 경쟁적으로 생기고 있는 현실이다. 그 중에서 몇 몇 큰 프랜차이즈업체는 미국, 유럽, 중국 등에도 진출을 하여 현지인의 입맛에 맞는 튀김 닭고기 메뉴를 개발하고 있다. Fried chicken is one of the most popular snacks and instant foods enjoyed by people of all ages. Recently, as chicken companies are franchised, many companies are competing with each other. Some of the largest franchise companies have also made inroads into the US, Europe and China to develop fried chicken menus to suit local tastes.
그러나 튀김은 유지를 계속 높은 온도를 유지하면서 조리하므로 튀김기름 뿐만 아니라 튀김제품 속의 유지도 산화, 중합 등의 화학적 반응을 일으켜 식품의 맛과 풍미를 저하시켜 제품의 품질을 빨리 저하시킨다(Kwang Jee Joo. Lipid content and fatty acid composition of various deep-fat fried foods. J. Korean Soc. Food Nutr. 20(2) 162-166 (1991)). However, since frying continues to be cooked at a high temperature, not only frying oil but also fats and oils in frying products cause chemical reactions such as oxidation and polymerization, which lowers the taste and flavor of foods, thereby rapidly degrading the quality of products (Kwang Jee Joo Lipid content and fatty acid composition of various deep-fat fried foods.J. Korean Soc.Food Nutr. 20 (2) 162-166 (1991)).
시중에 판매되고 있는 튀김류 중에서 야채튀김과 어묵튀김의 경우 제품의 총 지질함량이 24%를 상회하였는데 통닭튀김의 경우 45%로서 튀김류 제품 중에 높은 지질함량을 나타내는 것으로 보고되고 있다. 저장 중의 산가의 변화는 5-20℃에 저장 시는 대체로 완만한 증가를 나타낸 반면 30℃ 저장 시는 급격한 증가를 보여 산패가 빨리 진행되는 경향을 보인다고 한다. 각 튀김제품에서 추출한 지질의 지방산 조성은 모두 공통적으로 linoleic acid함량이 38.5-51.0%로 가장 많고, 다음으로 oleic acid의 함량이 22.9-28.7%, palmitic acid 10.5-16.9%로 불포화지방산의 함량이 높았다(시판 튀김제품의 저장 중의 변화 연구, 조은자, 신동화, Geon Yong Park, Ae Kyung Kim, Kyung Ai Park, Bo Kyung Jung, Chung Ho Bae and Myung Hee Kim. Acidification of frying oil used for chicken. J. Fd Hyg. Safety 18(1) 36-41 (2003)). Among the fried foods on the market, the total lipid content of the product was more than 24% in the case of vegetable frying and fish cake frying, and 45% of the fried chicken was reported to show high lipid content in the frying products. The change in acid value during storage showed a moderate increase in storage at 5-20 ℃, while the rapid increase in storage at 30 ℃ showed a tendency to accelerate rancidity. The fatty acid composition of lipids extracted from each fried product was the highest in linoleic acid (38.5-51.0%), followed by oleic acid (22.9-28.7%) and palmitic acid (10.5-16.9%). (Study of changes in storage of commercial fried products, Cho Eun-ja, Shin Dong-hwa, Geon Yong Park, Ae Kyung Kim, Kyung Ai Park, Bo Kyung Jung, Chung Ho Bae and Myung Hee Kim.Acidification of frying oil used for chicken.J. Fd Hyg Safety 18 (1) 36-41 (2003).
따라서 불포화 지방산의 함량이 높은 식용유지를 사용하고 제품의 총 지질함량이 높은 닭튀김제품의 경우 산화안정성, 기호성과 더불어 예방 의학적인 시대조 류에 맞추어 건강 기능성이 부여된 닭튀김 제품의 개발이 요구된다고 하겠다. Therefore, it is necessary to develop fried chicken products with healthy functional properties in accordance with the preventive medical era, as well as oxidative stability and palatability. would.
본 발명자들은 상기와 같은 결명자 추출물의 문제점을 해결하기 위해 예의 연구를 거듭한 결과 다양한 생리활성 효과를 갖는 보리와 옥수수 수염을 결명자와 함께 혼합하여 추출함으로써 결명자 추출물의 고미를 완화하고 기호도를 향상시킬 수 있음을 확인하고, 이를 이용하여 튀김용 조성물을 제조하고, 상기 튀김용 조성물로 제조된 튀김 식품이 종래의 것들 보다 우수한 식품적 특성이 있음을 확인하여 본 발명에 이르게 되었다.The present inventors have conducted a lot of research to solve the problems of the above-mentioned deficiency extract as a result of extracting by mixing the barley and corn whiskers with various bioactive effects with the deficiency can alleviate the taste of the extract of the deficiency and improve the palatability After confirming that, by using this to prepare a composition for frying, it was confirmed that the fried food prepared with the composition for frying has a better food characteristics than the conventional ones to reach the present invention.
본 발명의 목적은 항산화, 간장 보호, 혈당 강하 및 혈중 콜레스테롤 저하 활성을 갖는 결명자 혼합 추출물을 이용하여, 이를 함유한 튀김용 조성물을 제공하고, 상기 튀김용 조성물을 이용하여 제조된 저장안정성이 증대되고, 풍미 및 기호도가 우수한 튀김 식품을 제공하는 것이다.It is an object of the present invention to provide a frying composition containing the same, using an extract of a compound containing antioxidant, hepatic protection, hypoglycemic activity and hypocholesterolemic activity, and storage stability prepared using the frying composition is increased. To provide fried foods with excellent flavor, flavor and preference.
본 발명의 상기와 같은 목적은 볶은 결명자에 보리와 옥수수 수염을 혼합하여 결명자 혼합 추출물을 제조하고, 상기 추출물의 항산화 효과, 간 기능에 미치는 영향 및 혈당 개선 효과가 우수함으로 확인하고, 상기 결명자 혼합 추출물의 항산화, 간장 보호, 혈당 강하 및 혈중 콜레스테롤 저하 활성을 이용하여 튀김용 조성물을 제조하고, 상기 튀김용 조성물로 튀김 식품을 제조한 후, 제조된 튀김 식품이 저장안정성이 향상되고, 풍미 및 기호도가 우수함을 확인함으로써 달성되었다.The above object of the present invention is a mixture of barley and corn whiskers in the roasted to produce a defect extract mixture, confirming that the antioxidant effect of the extract, the effect on liver function and the effect of improving blood sugar, and the extract of the deficiency mixture The composition for frying is prepared using the antioxidant, hepatic protection, hypoglycemic activity and hypocholesterolemic activity of the frit, and after the frying food is prepared with the frying composition, the prepared frying food is improved in storage stability, flavor and preference Achieved by confirming excellent.
본 발명은 결명자 혼합 추출물을 함유한 튀김용 조성물의 제조방법을 제공한다.The present invention provides a method for producing a composition for frying containing the compound extract extract.
상기의 본 발명에 따른 결명자 혼합 추출물을 함유한 튀김용 조성물의 제조방법은 결명자를 세척, 건조하여 200 내지 250 ℃에서 10 내지 15 분 동안 볶는 단계; 보리를 각각 세척, 건조하여 190 내지 230 ℃에서 9 내지 13 분 동안 볶는 단계: 옥수수 수염을 세척하고 동결건조한 후 분쇄하여 분말화하는 단계; 상기 볶은 결명자 55 내지 60 중량%, 볶은 보리 20 내지 25 중량% 및 옥수수 수염 분말 18 내지 23 중량%를 열수로 추출하는 단계; 상기 결명자 혼합 추출물을 동결건조하여 분말화하는 단계; 및 상기 결명자 혼합 추출물 분말을 튀김가루와 혼합하는 단계로 이루어진다.Method for producing a composition for frying containing a blender extract according to the present invention is the step of washing, drying the roaster for 10 to 15 minutes at 200 to 250 ℃; Washing and drying the barley and roasting at 190 to 230 ° C. for 9 to 13 minutes, respectively: washing the corn stubble, lyophilizing and pulverizing to powder; Extracting 55 to 60% by weight of the roasted grains, 20 to 25% by weight of roasted barley and 18 to 23% by weight of corn beard powder with hot water; Lyophilizing the powder of the extract mixture to powder; And it comprises a step of mixing with the frying powder mixed with the compounder extract.
또한 본 발명은 상기와 같이 제조된 항산화, 간장 보호, 혈당 강하 및 혈중 콜레스테롤 저하용 결명자 혼합 추출물을 유효성분으로 함유하는 튀김용 조성물을 제공한다.In another aspect, the present invention provides a composition for frying containing the antioxidant extract, liver protection, lowering blood sugar and lowering cholesterol-lowering compound as an active ingredient prepared as described above.
본 발명에 따른 튀김용 조성물은 밀가루 44 내지 68 중량%, 소맥전분 10 내지 15 중량%, 타피오카 조제품 5 내지 10 중량%, 옥수수가루 5 내지 10 중량%, 보 리가루 3. 내지 4 중량%, 난백가루 3 내지 4 중량%, 고추씨가루 0.5 내지 1.5 중량%, 후추가루 0.1 내지 0.3 중량%, 마늘가루 0.2 내지 0.8 중량%, 생강가루 0.1 내지 0.3 중량%, 정제소금 1.0 내지 1.5 중량%, 백설탕 1.0 내지 2.0 중량%, 아몬드가루 0.2 내지 0.5 중량%, 아라비아검 0.1 내지 0.3 중량%, 베이킹 파우더 0.3 내지 0.8 중량% 및 결명자 혼합추출물 분말 2 내지 5 중량%로 구성되는 것을 특징으로 한다.The composition for frying according to the present invention is 44 to 68% by weight wheat flour, 10 to 15% by weight wheat flour, 5 to 10% by weight tapioca preparation, 5 to 10% by weight corn flour, 3 to 4% by weight barley powder, egg white 3 to 4% by weight of powder, red pepper seed powder 0.5 to 1.5% by weight, black pepper powder 0.1 to 0.3% by weight, garlic powder 0.2 to 0.8% by weight, ginger powder 0.1 to 0.3% by weight, refined salt 1.0 to 1.5% by weight, white sugar 1.0 to 2.0% by weight, almond flour 0.2 to 0.5% by weight, gum arabic 0.1 to 0.3% by weight, baking powder 0.3 to 0.8% by weight and characterized in that it comprises 2 to 5% by weight of the compound extract powder.
바람직하게는 본 발명에 따른 튀김용 조성물은 밀가루 57.0 중량%, 소맥전분 13.0 중량%, 타피오카 조제품 7.5 중량%, 옥수수가루 7.0 중량%, 보리가루 3.5 중량%, 난백가루 3.5 중량%, 고추씨가루 1.0 중량%, 후추가루 0.2 중량%, 마늘가루 0.5 중량%, 생강가루 0.2 중량%, 정제소금 1.1 중량%, 백설탕 1.5 중량%, 아몬드가루 0.3 중량%, 아라비아검 0.2 중량%, 베이킹 파우더 0.5 및 결명자 혼합추출물 분말 3.0 중량%로 구성된다.Preferably, the composition for frying according to the present invention is flour 57.0% by weight, wheat starch 13.0% by weight, tapioca crude product 7.5% by weight, corn flour 7.0% by weight, barley flour 3.5% by weight, egg white powder 3.5% by weight, red pepper seed powder 1.0% by weight %, Black Pepper Powder 0.2%, Garlic Powder 0.5%, Ginger Powder 0.2%, Refined Salt 1.1%, White Sugar 1.5%, Almond Powder 0.3%, Arabian Gum 0.2%, Baking Powder 0.5 and Clarifier Mixture Extract Powder 3.0% by weight.
또한 본 발명은 상기 튀김용 조성물에, 조성물 중량의 31%의 물을 가하여 튀김옷을 제조하는 단계; 상기 튀김옷에 튀김용 식품을 침지시켜 도포하는 단계; 상기 튀김옷이 도포된 튀김용 식품을 175 내지 185℃ 온도의 기름에서 9 내지 11분 간 1차 튀김하는 단계; 및 1차 튀김하고 3 내지 8분 후, 175 내지 185℃ 온도의 기름에서 1 내지 3분 간 2차 튀김하는 단계로 이루어진 튀김 식품의 제조 방법을 제공한다.In another aspect, the present invention comprises the steps of preparing a fry clothes by adding 31% of the weight of the composition to the fry composition; Immersing and applying the food for frying on the frying cloth; First frying the food for frying coated with the frying cloth in oil at a temperature of 175 to 185 ° C. for 9 to 11 minutes; And 3 to 8 minutes after the first frying, the second frying step is performed for 1 to 3 minutes in oil at a temperature of 175 to 185 ° C.
본 발명에서 튀김용 식품이라 함은 각종 야채, 육류 또는 해물과 같이 종래 튀김으로 제조되어 온 식품을 의미한다.In the present invention, the food for frying means food that has been prepared with conventional frying, such as various vegetables, meat, or seafood.
본 발명에서 튀김 옷이라 함은 상기 튀김용 식품에 도포하여 튀김 조리하기 위하여 사용되는 것으로 본 발명의 튀김용 조성물을 물과 혼합하여 제조된 것을 의미한다.In the present invention, the frying cloth is used to apply the frying food to the frying food, and means that the frying composition of the present invention is prepared by mixing with the frying composition.
또한 본 발명은 상기의 방법에 따라 제조된 항산화, 간장 보호, 혈당 강하 및 혈중 콜레스테롤 저하용 결명자 혼합 추출물을 유효성분으로 함유하는 튀김용 조성물로 제조된 튀김 식품을 제공한다.In another aspect, the present invention provides a fried food prepared with a composition for frying containing antioxidant extract, liver protection, lowering blood sugar and lowering blood cholesterol lowering compound prepared according to the above method as an active ingredient.
본 발명에 따라 바람직한 튀김 식품은 튀김 닭이다.Preferred fried food according to the present invention is fried chicken.
본 발명의 결명자 혼합 추출물을 함유한 튀김용 조성물로 제조된 튀김식품에 대한 저장안정성, 색상 및 관능평가를 실시한 결과, 종래의 튀김용 조성물로 제조된 튀김 식품과 비교하여, 산가가 종래의 튀김식품은 저장 7일째 산가가 0.92, 저장 14일째 1.19인 반면, 본 발명의 튀김 식품은 저장 21일째 0.74, 저장 28일째 1.01이었으며, 과산화물의 경우에도 종래의 튀김식품은 저장 21일째에 과산화물가가 48.184 meq/kg, 저장28일째에는 65.732 meq/kg인 반면, 본 발명의 튀김식품은 저장 28일째에도 과산화물가가 39.211로 나타나 저장 안정성이 매우 향상되었음을 알 수 있다. Storage stability, color, and sensory evaluation of the fried foods prepared with the composition for frying containing the compound of the present invention, as a result of the evaluation, compared to the fried foods prepared with the conventional frying composition, acid value is conventional fried foods While the acid value was 0.92 on the 7th day of storage and 1.19 on the 14th day of storage, the fried foods of the present invention were 0.74 on the 21st day of storage, 1.01 on the 28th day of storage, and even in the case of peroxides, the peroxide value was 48.184 meq / on the 21st day of storage. kg, on the 28th day of storage was 65.732 meq / kg, whereas the fried food of the present invention was found to have a peroxide value of 39.211 even on the 28th day of storage.
또한 색상에 있어서 본 발명의 결명자 혼합 추출물을 함유한 튀김용 조성물로 제조된 튀김 식품은 저장기간이 경과할수록 보다 짙은 갈색을 띠게 됨을 알 수 있었다. In addition, it can be seen that the fried foods prepared with the frying composition containing the compound extract of the present invention in color have a darker brown color as the storage period elapses.
또한 관능평가 결과 풍미, 바삭한 정도 및색상 기호도가 종래 튀김 식품 보다 우수한 것으로 평가되었고, 불쾌취는 감소된 것으로 평가 되었다.In addition, as a result of sensory evaluation, flavor, crispness and color preference were evaluated as superior to conventional fried foods, and discomfort was evaluated as being reduced.
이와 같이 본 발명에 따른 결명자 혼합 추출물 함유 튀김용 추출물로 제조된 튀김 식품은 항산화, 간장 보호, 혈당 강하 및 혈중 콜레스테롤 저하 활성을 갖는 결명자 혼합 추출물을 사용함으로써 저장안정성이 증대되고, 색상이 향상되었으며 풍미 및 기호도가 증진된 효과가 있어 산업상 매우 유용한 발명인 것이다.As described above, the fried food prepared with the extract for frying containing the extract according to the present invention has an increased storage stability, an improved color and a flavor by using the extract of the extract with antioxidant, liver protection, hypoglycemic activity and blood cholesterol lowering activity. And there is an enhanced effect of palatability is a very useful invention in the industry.
이하에서 본 발명의 바람직한 실시형태를 실시예를 참고로 보다 구체적으로 설명한다. 하지만 본 발명의 범위가 이러한 실시예에 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described in more detail with reference to Examples. However, the scope of the present invention is not limited to these examples.
실시예 1 : 결명자 혼합 추출물의 제조Example 1 Preparation of Cassia tora Mixture Extract
본 실시예에서 사용한 결명자는 2007년도 산 결명자를 재배지에서 구입하여 세척건조하여 전기 자동솥 온도 220℃에서 13분간 볶아서 사용하였다. 보리는 2007년도 생산된 국내산 보리를 영천시장에서 구입하여 세척건조하여 전기 자동솥 온도 210℃에서 11분간 볶아서 사용하였으며, 옥수수 수염은 2007년도 영천 재배지에서 구입하여 세척하고 동결건조한 후 분쇄하여 분말화하여 사용하였다. The defect used in this example was purchased from 2007 planter in the plantation, washed, dried and used for 13 minutes at 220 ℃ electric kettle temperature. Barley purchased domestic barley produced in 2007 from Yeongcheon market, washed and dried and roasted for 11 minutes at 210 ℃ in an automatic auto cooker. Corn whiskers were purchased from Yeongcheon plantation in 2007, washed, lyophilized and pulverized. Used.
상기의 볶은 결명자와 보리 및 옥수수 수염을 표 1의 배합비로 배합하여 100℃에서 3시간 동안 추출하여 결명자 혼합 추출물을 제조하였다.The roasted crystallized barley and barley and corn whiskers were formulated in a blending ratio of Table 1 and extracted at 100 ° C. for 3 hours to prepare a mixed extractor.
<표 1>TABLE 1
결명자와 보리 및 옥수수 수염의 배합비 (중량%)Blending ratio of barley and corn bran (% by weight)
상기의 배합비는 결명자 물 추출물에서 고미를 완화시킬 수 있는 볶은 보리와 옥수수 수염 분말의 첨가량 조건에 따른 예비실험으로 배합비를 구성하였다.The blending ratio was composed of a preliminary experiment according to the conditions of the addition amount of roasted barley and corn whisker powder, which can alleviate the bitterness in the water extract of Cassiae.
실시 예 2 : 결명자 혼합 추출물의 품질평가Example 2 Evaluation of Quality of the Cassiae Lacquer Extract
상기 실시예 1에서 제조한 결명자 혼합 추출물에 대한 가용성 고형분 함량, pH 및 산도, 색상 및 관능검사를 수행하였다. 관능검사를 제외한 모든 실험은 3반복으로 행하여 그 결과를 평균값±표준편차로 나타내었다.Soluble solids content, pH and acidity, color and sensory test of the extracts prepared in Example 1 was performed. All experiments except the sensory test were repeated three times, and the results were expressed as the mean value ± standard deviation.
(1) 가용성 고형분 함량(1) soluble solids content
결명자 혼합 추출물의 가용성 고형분(soluble solid)은 굴절당도계(hand refractometer, model NI. range : 0-35%, Atago, Japan)를 사용하여 상온에서 3회 측정한 후 °Brix로 나타내었다. The soluble solids of the extracts of the clarifier mixture were measured three times at room temperature using a hand refractometer (model NI.range: 0-35%, Atago, Japan) and expressed in ° Brix.
시험결과 결명자 혼합추출물의 가용성 고형분 함량은 8.6 °Brix로 나타났으며, 완료 시점은 3시간 이내였다.As a result, the soluble solids content of the M. dulciflora extract was 8.6 ° Brix, and the completion time was within 3 hours.
(2) pH 및 산도(2) pH and acidity
결명자 혼합 추출물의 pH는 pH 미터(Metrohm 635)를 사용하여 측정하였으며, 산도는 0.1 N NaOH를 사용하여 pH 8.2까지 적정하여 이때 소비된 0.1 N NaOH의 mL수를 젖산 %로 환산하였다. 그 결과 결명자 혼합 추출물의 pH는 6.75, 산도는 0.12%로 나타났다.The pH of the compound mixture extract was measured using a pH meter (Metrohm 635), the acidity was titrated to pH 8.2 using 0.1 N NaOH to convert the number of mL of 0.1 N NaOH consumed at this time to% lactic acid. As a result, the pH of the mixed extract of Clarifier was 6.75, and the acidity was 0.12%.
(3) 색상(3) color
결명자 혼합 추출물의 색상을 시험하기 위해, 색차계(CR-200, Minolta, Japan)를 사용하여 시료의 L*(lightness), a*(redness), 및 b*(yellowness)값을 측정하였다. 대조군으로 3% 결명자 단독 추출물을 사용하였다. In order to test the color of the Cassiae extract, a color difference meter (CR-200, Minolta, Japan) was used to measure the L * (lightness), a * (redness), and b * (yellowness) values of the sample. As a control, an extract of 3% C. deg. Was used alone.
그 결과 혼합 추출물의 L*값은 대조군에 비해 유의하게 높았으며, a*값은 대조군에 비해 유의하게 낮았으며 b*값 유의한 차이가 없는 것으로 나타나 혼합 추출물의 색상이 대조군에 비해 밝은 다갈색이었다. As a result, the L * value of the mixed extract was significantly higher than that of the control, the a * value was significantly lower than the control, and the b * value was not significantly different.
<표 2>TABLE 2
결명자 혼합 추출물의 색상 Colors Of Cassiae Blend Extract
1) 3% 결명자 단독 추출물. 1) Extract 3% Cassia alone.
2) Mean±standard deviation. 2) Mean ± standard deviation.
3) Mean Duncan's multiple range test for samples(significantly p〈0.05). 3) Mean Duncan's multiple range test for samples (significantly p <0.05).
(4) 관능검사(4) sensory evaluation
결명자 혼합 추출물의 관능검사를 위하여, 훈련된 25명의 관능요원이 향미, 쓴맛, 신맛, 불쾌한 맛, 색상기호도, 및 종합적인 기호도에 대하여 5점 척도법으로 매우 좋다(5점), 좋다(4점), 보통(3점), 나쁘다(2점), 매우 나쁘다(1점)로 평가하였다. 관능검사 결과는 관능요원 25명이 평가한 평균값±표준편차로 나타내었다. 유의성은 SPSS-프로그램의 던컨 다중 범위 시험(Duncan's multiple range test)에 의하여 검증하였다.For the sensory test of the extracts of the compound, 25 trained sensory agents were very good (5 points), good (4 points) for flavor, bitterness, sourness, unpleasant taste, color symbolism, and overall preference. It evaluated as normal (3 points), bad (2 points), and very bad (1 point). Sensory test results were expressed as mean ± standard deviation evaluated by 25 sensory personnel. Significance was verified by the Duncan's multiple range test of the SPSS-program.
상기의 관능검사 결과를 표 3에 나타내었다. 그 결과 향미와 구수한 맛은 혼합추출물이 대조군에 비해 유의하게 높았으며, 쓴맛과 불쾌한 맛은 대조군이 유의하게 높게 나타났다. 색상 기호도는 혼합 추출물이 높게 나타났으나 유의적인 차이는 없었으며, 종합적인 기호도는 혼합 추출물이 평점 3.8로 대조군보다 유의적으로 높게 나타났다.Table 3 shows the sensory test results. As a result, the flavor and taste were significantly higher in the mixed extract than the control, and the bitter and unpleasant taste were significantly higher in the control. The color acceptability was higher in the mixed extract, but there was no significant difference. The overall acceptability of the mixed extract was significantly higher than the control group with a score of 3.8.
<표 3>TABLE 3
결명자 혼합 추출물의 관능적 특성 Sensory Characteristics of the Cassia L. C. Extract
1) 3% 결명자 단독 추출물. 1) Extract 3% Cassia alone.
2) Mean±standard deviation. 2) Mean ± standard deviation.
3) Mean Duncan's multiple range test for samples(significantly p〈0.05). 3) Mean Duncan's multiple range test for samples (significantly p <0.05).
실시예 3 : 결명자 혼합 추출물의 항산화 효과Example 3 Antioxidant Effect of Cassiae Mixed Extract
결명자 혼합 추출물의 항산화효과를 강 등{Kang YH, Park YK, Lee GD. The nitrite scavenging and electron donating ability of phenolic compounds. Korean J. Food Sci. Technol. 28: 232-239 (1996)}의 방법을 변형한 전자공여능(electron donating abilities)으로 나타내었다. 즉, 결명자 혼합 추출물 0.2mL에 4x10-4M DPPH용액(α-diphenyl-picrylhydrazyl, 99.9% EtOH에 용해) 0.8mL, 0.1M 인산염 완충액(pH 6.5) 2mL와 99.9% EtOH 2mL를 가하여 총액의 부피가 5mL가 되도록 하였다. 이 반응액을 약 10초간 혼합하고 실온에 10분 방치한 후 분광광도계(UV/VIS spectrometer, Jasco, Japan)를 사용하여 525nm에서 흡광도를 측정하였 다. 전자공여능은 혼합 추출물의 첨가 전 후의 차이를 백분율로 나타내었다.Antioxidant effect of the extracts from the cultivars Kang, et al. {Kang YH, Park YK, Lee GD. The nitrite scavenging and electron donating ability of phenolic compounds. Korean J. Food Sci. Technol. 28: 232-239 (1996)} are shown as modified electron donating abilities. In other words, add 0.2 ml of the compound extract, add 0.8 ml of 4x10 -4 M DPPH solution (α-diphenyl-picrylhydrazyl, dissolved in 99.9% EtOH), 2 ml of 0.1 M phosphate buffer (pH 6.5) and 2 ml of 99.9% EtOH, 5 mL was made. The reaction solution was mixed for about 10 seconds and allowed to stand at room temperature for 10 minutes, and then absorbance was measured at 525 nm using a spectrophotometer (UV / VIS spectrometer, Jasco, Japan). The electron donating ability was expressed as a percentage before and after addition of the mixed extract.
EDA(%) = (1 - A/B) x 100 EDA (%) = (1-A / B) x 100
A: 혼합 추출물 첨가구의 흡광도A: absorbance of the mixed extract addition
B: 혼합 추출물 무첨가구의 흡광도B: absorbance of mixed extract-free
상기의 시험 결과 결명자 혼합 추출물의 전자공여능은 63.15%로 나타나 우수한 전자공여 효과를 나타냄을 알 수 있었다.As a result of the above test, the electron donating ability of the extract of the Clarifier extract was 63.15%, indicating an excellent electron donating effect.
실시예 4 : 결명자 혼합 추출물의 간 기능에 미치는 영향Example 4 Effect on the Liver Function of the Cassiae Fructus Extract
1) 재료 및 실험 동물 1) materials and laboratory animals
결명자 혼합 추출물을 동결 건조하여 분말화하고, 이를 실험동물 식이로 사용하였으며, 기타의 시약은 특급시약을 사용하였다. Lactobacillus mixed extract was lyophilized and powdered, and this was used as an experimental animal diet, and other reagents were used as a special reagent.
실험동물은 6주령 된 스프라귀 다우리(Sprague Dawley)계 수컷 흰쥐를 (주)효창 사이언스로부터 구입하여 1주일간 기본식이로 적응시킨 후, 난괴법에 의해 정상군, 사염화탄소 투여 대조군, 3% 결명자 혼합 추출물 투여군으로 나누어 5주간 사육하였으며, 물과 실험식이는 자유롭게 공급하였다. 본 실시예에 사용한 식이는 AIN-76 식이 조성(옥수수 전분 45%, 카제인 20%, 자당 20%, 옥수수유 5%, 셀룰로오스 5%, 미네랄 혼합물 3.5% 비타민 혼합물 1%, 메티오닌 0.3%, 염화 콜린 0.2%)에 준하여 결명자 혼합추출물 동결건조 분말을 3% 되게 기본식이에 더하여 공급하였다. The experimental animals were purchased from 6-week-old Sprague Dawley male rats from Hyochang Science Co., Ltd., and adjusted to the basic diet for 1 week. Divided into extract administration group was bred for 5 weeks, water and experimental diet was freely supplied. The diet used in this Example is AIN-76 dietary composition (45% corn starch, 20% casein, 20% sucrose, corn oil 5%, cellulose 5%, mineral mixture 3.5% vitamin mixture 1%, methionine 0.3%, choline chloride) 0.2%) was added to the basic diet to the lyophilizer extract extract lyophilized powder 3%.
식이 섭취량은 격일에 한번 측정하였으며 체중은 매주 측정하였다. 실험군에는 사염화탄소 : 올리브를 1:1의 비율로 혼합한 용액을 1mL/kg.bw.day씩 1일 간격으로 2회 복강 내로 투여하였고 대조군에는 동량의 올리브를 동일한 방법으로 투여하였다. 실험동물은 처치 전 12시간동안 물만 주고 금식시켰으며 마지막 사염화탄소 투여 24시간 후 에테르 마취하여 개복한 후 복부대동맥으로부터 채혈하고, 간, 심장, 신장 비장을 적출하여 식염수로 씻은 후 트리밍(trimming)하여 무게를 측정한 후 측정 시 까지 -70℃에서 보관하였다. 채취한 혈청은 실온에서 1시간 이내로 방치시킨 다음 3000rpm에서 10분간 원심 분리하여 혈청을 분리하였으며, 분석 전까지 -70℃에서 보관하였다. 실험결과는 SAS를 이용하여 평균±표준편차로 나타내었으며, 유의차 검증은 P〈0.05 수준에서 던컨 다중비교법에 의해 검증하였다. Dietary intake was measured every other day and body weight was measured weekly. In the experimental group, a solution containing a mixture of carbon tetrachloride and olives in a ratio of 1: 1 was administered intraperitoneally twice a day at 1 mL / kg.bw.day, and the same amount of olive was administered to the control group in the same manner. The animals were fasted with water only for 12 hours before treatment. 24 hours after the last administration of carbon tetrachloride, anesthetized with anesthesia, and opened from the abdominal aorta. The liver, heart, and kidney spleens were extracted, washed with saline, and trimmed. After the measurement was stored at -70 ℃ until the measurement. The collected serum was left at room temperature within 1 hour and then centrifuged at 3000 rpm for 10 minutes to separate serum and stored at -70 ℃ until analysis. The experimental results were expressed as mean ± standard deviation using SAS, and significant difference was verified by Duncan's multiple comparison method at P <0.05 level.
2) 혈청 분석2) Serum Analysis
혈청 중 총콜레스테롤은 콜레스테자임-V(Cholestezyme-V), 중성지방은 트리글리자임-V(Triglyzyme-V)를 이용하여 측정하였다.Total cholesterol in serum was measured using Cholestezyme-V, and triglyceride was measured using Triglyzyme-V.
3) 효소의 조제 및 분석3) Preparation and Analysis of Enzymes
간 조직 1g당 15mL의 0.25M 자당/0.5M EDTA를 가하여 빙냉 하에서 테플론 포터-엘베젬 균질화기(Teflon Potter-Elvehjem homogenizer)로 마쇄하여 얻은 균질액을 600 x g에서 10분간 원심분리하여 얻은 상층액을 카랄라제 활성 측정 효소원으로 사용하였다. 이 상층액을 다시 10,000 x g에서 30분간 원심분리하여 포스트 미 토콘드리아 분획(post mitochondrial fraction)을 얻어 이를 유해산소 제거효소(SOD; superoxide dismutase), 항산화 효소(GPx; glutathione peroxide) 활성 측정에 사용하였으며, 이를 다시 105,000 x g에서 1시간 동안 원심분리하여 얻은 세포질 분획(cytosolic fraction)은 글루타치온 S 전이효소(GST; glutathione S-transferase) 활성 측정에 사용하였다. 카탈라제 활성 측정은 기질인 수산화 과산화물( hydroxide peroxide)이 분해되는 정도를 측정하는 어베이{Abei H. Catalase. In "Methods of enzymatic analysis " Vergmeyer M.U.(ed.) Academic Press, New YORK. 2: 673-679(1974)}의 방법에 준하였고, SOD 활성도는 마크룬드{Marklund S and Marklund C.T. Involvement of the suproxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase Eur.J. Biochem. 47: 469-473 (1974){의 방법, GPx는 로렌스와 버크{Lawrence R.A. and Burk R.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Comm. 71: 952-961 (1976)}의 방법에 의하여 측정하였다.The supernatant obtained by centrifuging the homogenate obtained by grinding with a Teflon Potter-Elvehjem homogenizer under ice cooling by adding 15 mL of 0.25 M sucrose / 0.5 M EDTA per 1 g of liver tissue for 10 minutes at 600 xg. It was used as a source of enzyme for measuring caralase activity. The supernatant was further centrifuged at 10,000 xg for 30 minutes to obtain a post mitochondrial fraction, which was used to measure the activity of superoxide dismutase (SOD) and glutathione peroxide (GPx). The cytosolic fraction obtained by centrifugation at 105,000 xg for 1 hour was used to measure glutathione S-transferase (GST) activity. Catalase activity measurement is a measure of the degree of degradation of the substrate, hydroxide peroxide (Abei H. Catalase. In "Methods of enzymatic analysis" Vergmeyer M.U. (ed.) Academic Press, New YORK. 2: 673-679 (1974)} and the SOD activity was Marklund S and Marklund C.T. Involvement of the suproxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase Eur.J. Biochem. 47: 469-473 (1974), the method of GPx by Lawrence and Burke {Lawrence R.A. and Burk R.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Comm. 71: 952-961 (1976).
4) 간 조직 중 과산화지질 및 지질함량 측정4) Measurement of lipid peroxide and lipid content in liver tissue
간 1g에 1.15% KCl 9mL를 가하여 테플론 포터-엘베젬 균질화기로 마쇄한 후 600x g에서 10분간 원심분리하여 그 상층액을 과산화지질분석을 위한 시료로 사용하였다. 과산화지질의 분석은 오가와 등{Ohkawa H. Ohishi N. and Yagi K Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:35-41 (1979)}의 방법에 따라 분석하였으며, 표준물질로는 1,1,3,3,-테트라에톡시프로판(1,1,3,3,-tetraethoxypropane)을 사용하였다. 9 mL of 1.15% KCl was added to 1 g of liver, and triturated with a Teflon porter-elbezem homogenizer, followed by centrifugation at 600x g for 10 minutes to use the supernatant as a sample for lipid peroxide analysis. The analysis of lipid peroxides was carried out in Ohgawa et al. {Ohkawa H. Ohishi N. and Yagi K Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 35-41 (1979)}, and 1,1,3,3, tetraethoxypropane (1,1,3,3, tetraethoxypropane) was used as a standard.
간조직 중의 지질은 폴크{Folch J. Lees M. and Sloane G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:496-509 (1957)} 법으로 추출한 후 키트를 사용하여 콜레스테롤과 트리글리세라이드의 함량을 분석하였다.Lipids in liver tissues are described by Folch J. Lees M. and Sloane G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 496-509 (1957)} and the kit was used to analyze the contents of cholesterol and triglycerides.
5) 단백질 정량5) Protein Quantitation
각 효소원의 단백질량은 로우리{Lowry O.H. Rosebrough N.J. and Farr A.L. and Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193: 265-275 (1951)}법에 의해 정량하였으며, 표준단백질로는 소혈청알부민(BSA; bovine serum albumin)을 사용하였다.The protein amount of each enzyme source was Lowry O.H. Rosebrough N.J. and Farr A.L. and Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193: 265-275 (1951)} and bovine serum albumin (BSA) was used as a standard protein.
6) 체중 증가량 및 간 중량의 변화6) change in weight gain and liver weight
상기와 같은 실험 결과, 사염화탄소 처리한 실험동물의 체중증가량, 간 중량에 미치는 혼합추출물의 영향을 표 4에 나타내었다. 먼저 체중증가량은 사염화탄소투여 대조군은 정상군에 비해 체중증가량이 적었고, 3% 결명자 혼합추출물 투여군은 정상군에 비해 체중증가량이 컸으나 군 간에 유의적인 차이는 없었다.As a result of the above experiment, the effects of the mixed extracts on the weight gain and liver weight of the carbon tetrachloride treated animals were shown in Table 4. First, the weight gain of the carbon tetrachloride control group was less than that of the normal group, and the 3% CLA extract group was significantly higher than the normal group, but there was no significant difference between the groups.
간 중량의 경우는 사염화탄소투여 대조군이 정상군에 비해 간 중량이 약 16.2% 정도 증가된 현상을 나타내었으며, 3% 결명자 혼합 추출물 투여군과 사염화 탄소투여 대조군과는 간 중량에 유의한 차이는 없었다. 간 중량의 증가는 사염화탄소에 의해 간의 세포막이 손상되어 투과성이 증가하여 부종 및 지방의 변성으로 인하여 간장이 비대해지는데 원인이 있는 것으로 알려져 있다.In the liver weight, the carbon tetrachloride control group showed an increase of about 16.2% of the liver weight compared to the normal group, and there was no significant difference in the liver weight between the control group administered with the 3% clarifier extract and the carbon tetrachloride control group. Increasing liver weight is known to be caused by carbon tetrachloride damage to the liver cell membrane to increase permeability, resulting in hypertrophy of the liver due to edema and degeneration of fat.
<표 4>TABLE 4
체중 및 간 중량의 변화Changes in body weight and liver weight
1)정상인 군, 2)사염화탄소투여군, 3)3% 혼합 추출물+사염화탄소 투여군, 4)평균±표준편차, 5)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) normal group, 2) carbon tetrachloride group, 3) 3% mixed extract + carbon tetrachloride group, 4) mean ± standard deviation, 5) Mean Duncan's multiple range test for samples (significantly p <0.05).
7) 혈청 및 간장의 지질함량7) Lipid content of serum and liver
혈청지질함량의 경우 콜레스테롤함량은 정상군에 비해 사염화탄소 투여군이 낮은 경향을 나타내었으나 정상군과 유의적인 차이가 없었으며, 3% 결명자 혼합 추출물 투여군도 정상군과 유의한 차이가 없었다. 중성지방 함량의 경우 사염화탄소 투여군이 가장 높은 경향을 나타내었으나 정상군 및 3% 결명자 혼합 추출물 투여군 과 유의한 차이가 없었다. In the case of serum lipid content, the cholesterol tetrachloride group showed lower tendency than the normal group, but there was no significant difference from the normal group, and the 3% deficiency mixed extract group was not significantly different from the normal group. In the triglyceride content, the carbon tetrachloride treated group showed the highest tendency, but there was no significant difference between the normal group and the 3% unfixed extract group.
간장 중의 지질함량의 경우, 콜레스테롤함량은 정상군에 비해 사염화탄소투여군과 3% 결명자 혼합 추출물 투여군의 함량이 유의하게 낮게 나타났다. 반면에 중성지방의 함량은 모든 실험군에 있어서 유의한 차이를 보이지 않았다.In the case of lipid content in the liver, cholesterol content was significantly lower in the carbon tetrachloride administration group and the 3% glentocin extract group than the normal group. On the other hand, triglyceride content did not show a significant difference in all experimental groups.
이러한 실험결과를 종합적으로 판단해볼 때, 사염화탄소 투여 시 흰쥐의 체내 지질함량은 실험조건 등에 영향을 받는 것으로 사료되며, 혼합추출물 등이 본 발명의 실험조건에서는 혈청과 간장의 지질함량에 영향을 미치지 않는 것으로 생각된다.Judging from the results of these experiments, it is considered that the lipid content of the rats is affected by the experimental conditions when the carbon tetrachloride is administered, and the mixed extracts do not affect the lipid content of the serum and the liver under the experimental conditions of the present invention. It is thought to be.
<표 5>TABLE 5
혈청 및 간장의 지질함량Lipid content in serum and liver
1)정상인 군,2)사염화탄소투여군,3)3% 결명자 혼합 추출물+사염화탄소투여군,4)평균±표준편차,5)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) normal group, 2) carbon tetrachloride group, 3) 3% clarifier mixed extract + carbon tetrachloride group, 4) mean ± standard deviation, 5) Mean Duncan's multiple range test for samples (significantly p <0.05).
8) 간조직 중 과산화지질의 함량8) Content of lipid peroxide in liver tissue
혼합 추출물이 사염화탄소투여 대조군의 지질과산화물 생성에 미치는 영향은 TBARS 함량의 생성으로 나타내었다(표 6). 그 결과 사염화탄소투여 대조군의 TBARS의 함량이 정상군보다 현저히 높은 경향을 나타내어 유의한 차이를 나타내었으며, 3% 결명자 혼합 추출물 투여군의 TBARS의 함량은 정상군과 유의적인 차이를 나타내지 않았다.The effect of the mixed extract on the lipid peroxide production of the carbon tetrachloride control group was represented by the production of TBARS content (Table 6). As a result, the TBARS content of the carbon tetrachloride control group tended to be significantly higher than that of the normal group, showing a significant difference, and the TBARS content of the 3% CLA extract group was not significantly different from the normal group.
<표 6>TABLE 6
간조직 중 TBARS의 함량TBARS content in liver tissue
1)정상인 군, 2)사염화탄소 투여군, 3)3% 결명자 혼합 추출물+사염화탄소 투여군,4)Thiobarbituric acid reactive substances,5)평균±표준편차,6)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) normal group, 2), carbon tetrachloride administration group, 3) 3% of Cassia tora mixed extract + carbon tetrachloride administration group, 4) Thiobarbituric acid reactive substances, 5) mean ± SD, 6) Mean Duncan's multiple range test for samples (significantly p <0.05) .
9) 간조직중 효소활성변화9) Changes of enzyme activity in liver tissue
간조직중의 효소활성 변화는 표 7에 나타내었다. 카탈라제는 체내에서 지방의 자동산화 및 유기물의 산화로 생긴 H2O2를 분해하여 무독화시키는 자유 라디칼 소거(free radical scavenging) 효소 중의 하나이다. 사염화탄소 투여 대조군의 카탈라제 활성은 실험군중에 가장 낮았으며, 정상군과 유의적인 차이를 나타내었다. 3% 결명자 혼합 추출물 투여군은 카탈라제 활성이 증가되어 정상군과 유의한 차이를 나타내지 않았다. SOD는 유해산소(superoxide) 라디칼을 H2O2로 전환시켜 해독하는 역할을 하는데, 3% 결명자 혼합 추출물 투여군은 사염화탄소 투여 대조군에 비해 SOD 활성이 유의하게 높았으며, 정상군과는 유의한 차이를 나타내지 않았다. GPx는 항산화제 효소로서 체내에 있는 글루타치온을 기질로 하여 과산화지질과 H2O2의 무독화에 관여하는 효소이다. 본 발명에서 GPx 활성은 사염화탄소 투여 대조군에서 가장 높았으나 정상군과 유의한 차이는 나타내지 않았으며, 3% 결명자 혼합 추출물 투여군은 사염화탄소 투여 대조군에 비해 유의하게 낮았다. 이러한 결과는 3% 결명자 혼합 추출물이 사염화탄소에 의한 자유 라디칼의 생성을 저하시킨 것으로 생각된다. The enzyme activity change in liver tissue is shown in Table 7. Catalase is one of the free radical scavenging enzymes that decomposes and detoxifies H 2 O 2 resulting from the automatic oxidation of fats and the oxidation of organics in the body. The catalase activity of the carbon tetrachloride-administered control group was the lowest among the experimental groups and was significantly different from the normal group. The group treated with the 3% L. oleracea extract did not show a significant difference from the normal group due to increased catalase activity. SOD converts superoxide radicals into H 2 O 2 To convert and detoxify, 3% clarifier mixed extract group was significantly higher SOD activity than carbon tetrachloride control group, and did not show a significant difference from the normal group. GPx is an antioxidant enzyme that is involved in the detoxification of lipid peroxide and H 2 O 2 by using glutathione in the body as a substrate. In the present invention, GPx activity was the highest in the carbon tetrachloride control group, but did not show a significant difference from the normal group, and the 3% clarifier mixed extract administration group was significantly lower than the carbon tetrachloride control group. These results are believed to be the 3% clarifier mixed extract reduced the production of free radicals by carbon tetrachloride.
<표 7>TABLE 7
간조직의 효소활성의 변화 Changes of Enzyme Activity in Liver Tissues
1)정상인 군, 2)사염화탄소투여군, 3)3% 결명자 혼합 추출물+사염화탄소 투여군,4)평균±표준편차,5)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) normal group, 2) carbon tetrachloride administration group, 3) 3% clarifier mixed extract + carbon tetrachloride administration group, 4) mean ± standard deviation, 5) Mean Duncan's multiple range test for samples (significantly p <0.05).
실시예 5 : 결명자 혼합 추출물의 혈당치 개선에 미치는 영향Example 5 Effect on the Improvement of Blood Glucose Levels of the Cassia L. C. Extract
1) 재료 및 실험 동물 1) materials and laboratory animals
실험동물은 평균체중이 105±10g인 수컷 스프라귀 다우리 래트를 효창 사이언스로부터 구입하여 고형식이로 일주일간 환경에 적응시킨 후 난괴법으로 각 군별로 10마리씩으로 나누었다. 당뇨유발은 실험식이 일주일 후 실험동물을 16시간 절식시킨 후 스트렙토조토신(Sigma Chem. Co. MO. USA)을 0.01M citrate buffer(pH 4.2)에 녹여 50mg/kg/체중 농도로 1회 복강에 주사하였으며, 비공복 혈당농도가 200 mg/dL이상일 경우에 당뇨로 간주하였다. 정상군은 당뇨군과 동일한 스트레스를 주기위해 0.01M 시트르산염 완충액을 복강에 주사하였다.The experimental animals were purchased from Hyochang Science for male Sprague Dawley rats with an average weight of 105 ± 10 g, and were adapted to the environment for one week in solid form, and divided into 10 groups in each group by the ingot method. Diabetic induction was fasted for 16 hours after one week of the experimental diet, and then dissolved in streptozotocin (Sigma Chem. Co. MO. USA) in 0.01M citrate buffer (pH 4.2) at once in the abdominal cavity at 50 mg / kg / body weight. Injections were made and diabetes was considered when the fasting glucose level was above 200 mg / dL. The normal group was injected intraperitoneally with 0.01M citrate buffer to give the same stress as the diabetic group.
모든 실험군은 AIN-76 조제식이와 물을 자유롭게 섭취하도록 하면서 3주간 사육하였다. 실험식이군은 정상군, 정상당뇨군, 3% 혼합추출물 첨가군의 3개군으로 나누었다. 체중은 주 1회 측정하였으며, 사육실의 온도는 21±2℃, 습도는 60±5%로 조정하였으며, 명암은 12시간 간격으로 점등 및 소등하였다. 식이섭취량은 급여량과 잔여량의 차이로 측정하였으며, 식이효율(food efficiency ratio, FER)은 3주간의 체중증가량을 같은 기간의 식이섭취량으로 나누어 산출하였다.All experimental groups were reared for 3 weeks with a free diet of AIN-76 and water. The experimental diet group was divided into three groups: normal group, normal diabetic group, and 3% mixed extract addition group. Body weight was measured once a week, the temperature of the nursery was adjusted to 21 ± 2 ℃, humidity 60 ± 5%, the contrast was turned on and off every 12 hours. Dietary intake was measured by the difference between the amount of food intake and the remaining amount. The food efficiency ratio (FER) was calculated by dividing the weight gain over three weeks by the intake of the same period.
2) 혈당 측정과 혈액, 장기의 수집과 처리2) Blood glucose measurement and collection and processing of blood and organs
혈당은 실험식이 시작 1주일 후부터 공복 시 꼬리정맥에서 채혈 후 글루코-테스터(Gluco-Tester; Life Scan Inc. USA)를 이용하여 매주 측정하였다. 실험동물은 희생하기 12시간 전부터 절식 시킨 후 에틸에테르로 마취하여 에틸렌 디아민 테트라아세틱에시드(ethylene diamine tetraacetic acid) 10mL씩 넣은 주사기로 심장에서 채혈하였다. 혈액을 -5℃, 3000rpm에서 15분간 원심 분리하여 얻은 혈청으로 중성지질, 총콜레스테롤 및 HDL 콜레스테롤 함량을 효소적 평가 키트(enzymatic assay kit, Nissui Pham. Co. Ltd., Japan)로 측정하였으며, LDL 콜레스테롤함량은 총 콜레스테롤에서 HDL 콜레스테롤 함량을 뺀 것으로 하였다.Blood glucose was measured weekly using a Gluco-Tester (Life Scan Inc. USA) after blood collection from the fasting tail vein from one week after the start of the experiment. Animals were fasted for 12 hours before sacrifice, anesthetized with ethyl ether, and blood was collected from the heart with a syringe containing 10 mL of ethylene diamine tetraacetic acid. Serum obtained by centrifuging blood at -5 ° C and 3000 rpm for 15 minutes was used to measure neutral lipid, total cholesterol, and HDL cholesterol content by enzymatic assay kit (Nissui Pham. Co. Ltd., Japan). Cholesterol content was calculated by subtracting HDL cholesterol content from total cholesterol.
3) 체중, 식이섭취량 및 식이효율 3) weight, dietary intake and dietary efficiency
3% 결명자 혼합 추출물 첨가식이가 당뇨쥐에 있어서 당뇨병 증세의 개선에 미치는 영향을 조사하기 위하여 각 실험식이로 3주간 사육한 흰쥐의 체중증가량, 식이섭취량 및 식이효율은 표 8과 같다.The weight gain, dietary intake and dietary efficiency of the rats bred for 3 weeks in each experimental diet were investigated in order to investigate the effect of the diet with the 3% Cultivator mixed extract on diabetic rats.
체중증가량은 3% 결명자 혼합 추출물 첨가군은 정상당뇨군에 비하여 유의하게 높았으며, 정상군보다는 낮게 나타났다. 식이섭취량은 정상당뇨군의 경우가 정상군이나 3% 결명자 혼합 추출물 첨가군보다 유의하게 높게 나타났으며, 정상군과 3% 결명자 혼합 추출물 첨가군 간에는 유의적인 차이가 없었다. 식이효율은 정상군이 17.61%로 가장 높았으며, 정상당뇨군이 4.54%로 가장 낮게 나타났다. 3% 결명자 혼합 추출물 첨가군의 식이효율은 12.03%로 정상군 보다는 낮았다.The weight gain was significantly higher in the group with the 3% Cultivator extract, and lower than in the normal group. The dietary intake was higher in the normal diabetic group than in the normal group or the 3% undetermined group, but there was no significant difference between the normal group and the 3% undetermined group. Dietary efficiency was highest in the normal group (17.61%) and lowest in the normal diabetes group (4.54%). The dietary efficiency of the group added with 3% L. oleracea extract was 12.03%, which was lower than that of the normal group.
<표 8> TABLE 8
당뇨쥐의 체중, 식이섭취량 및 식이효율Weight, Dietary Intake, and Dietary Efficiency of Diabetic Rats
1)평균±표준편차,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) Mean ± standard deviation, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
4) 혈당강하에 미치는 영향4) Effect on blood sugar drop
3% 결명자 혼합 추출물 첨가식이로 3주간 사육한 당뇨쥐의 혈당은 표 9와 같다. 정상당뇨쥐의 경우 404.5mg/dL로 당뇨혈당을 나타내었으나, 정상군은 108.6mg/dL, 3% 결명자 혼합 추출물 첨가구은 123.3mg/dL로 두 그룹 간에 유의한 차이를 보이지 않았다.The blood glucose levels of diabetic rats bred for 3 weeks with the addition of 3% Cultivator mixed extract are shown in Table 9. Diabetic rats showed diabetes mellitus at 404.5 mg / dL, but the normal group was 108.6 mg / dL and 33.3% of the group with the extract added to 123.3 mg / dL, showing no significant difference between the two groups.
<표 9>TABLE 9
당뇨쥐의 혈당(mg/dL)Blood Sugar (mg / dL) in Diabetic Rats
1)평균±표준편차,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) Mean ± standard deviation, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
5) 혈중 지질농도에 미치는 영향5) Effect on blood lipid concentration
3% 결명자 혼합 추출물 첨가식이로 3주간 사육한 당뇨쥐의 혈중 지질농도는 표 10과 같다. 혈중 총콜레스테롤은 정상군과 3% 결명자 혼합 추출물 첨가군 간에 유의적인 차이가 없었으며, 정상당뇨군은 102.25mg/dL로 가장 높게 나타났다. 중성지방도 총콜레스테롤 수준과 같은 경향을 나타내어 정상당뇨군이 가장 높았다.Serum lipid concentrations of diabetic rats bred for 3 weeks with the addition of 3% Cultivator mixed extract are shown in Table 10. Serum total cholesterol was not significantly different between the normal group and the 3% deficiency mixed extract group. The normal diabetic group was the highest at 102.25mg / dL. Triglycerides also showed the same trend as total cholesterol level, which was the highest in the normal diabetic group.
고밀도 콜레스테롤함량은 정상당뇨군이 24.54mg/dL로 가장 낮았으며, 정상군과 3% 결명자 혼합 추출물 첨가군 간에는 유의적인 차이가 없었다. 반면에 저밀도 콜레스테롤 함량은 정상당뇨군이 39.16mg/dL로 가장 높은 수준을 나타내었으며, 정상군은 29.37mg/dL, 3% 결명자 혼합 추출물 첨가군은 31.41mg/dL로 유의적인 차이가 없었다.The high density cholesterol content was the lowest in the normal diabetic group (24.54mg / dL), and there was no significant difference between the normal group and the 3% unfertilized group. On the other hand, low-density cholesterol content was 39.16mg / dL in the normal diabetic group, and 29.37mg / dL in the normal group, and 31.41mg / dL in the 3% deficiency mixed extract group.
<표 10>TABLE 10
당뇨쥐의 혈중지질농도(mg/dL)Blood Lipid Concentrations in Diabetic Rats (mg / dL)
1)평균±표준편차,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) Mean ± standard deviation, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
실시예 6 : 결명자 혼합 추출물 함유 튀김용 조성물 제조Example 6: Preparation of frying compound containing extract extract
본 실시예에서는 결명자 혼합 추출물을 이용하여 튀김용 조성물을 제조하였다. In this embodiment, the composition for frying was prepared by using the extract of the compound.
튀김가루에 배합되는 밀가루(밀:미국산), 소맥전분(밀), 변성전분 조제품(변성타피오카 전분, 덱스트린, 포도당, L-글루타민산나트륨), 옥수수가루, 보리가루, 고추씨가루, 후추가루, 마늘가루, 생강가루는 태백식품에서 구입하였으며, 정제소금, 백설탕, 아몬드가루는 시내마트에서, 아라비아검은 이슬나라에서 구입하여 사용하였다. Wheat flour (wheat: USA), wheat starch (wheat), modified starch preparation (modified tapioca starch, dextrin, glucose, sodium L-glutamate), corn flour, barley flour, red pepper seed powder, black pepper powder, garlic powder , Ginger powder was purchased from Taebaek food, refined salt, white sugar, and almond powder were purchased from Sinai Mart and Arabian gum from the dew country.
상기 실시예 1에서 제조한 결명자 혼합 추출물을 동결 건조하여 튀김가루에 배합하였다. 제조는 예비실험에 의해 표 11의 배합비로 하였다.Freeze-dried extract was prepared in Example 1, the blender prepared in Fried powder. The preparation was made into the compounding ratio of Table 11 by preliminary experiment.
<표 11>TABLE 11
튀김가루 배합표Fried Powder Formulation Table
실시예 7 : 결명자 혼합 추출물 함유 튀김용 조성물을 이용한 튀김 닭의 제조 Example 7: Preparation of fried chicken using a composition for frying containing a compound extract extract
본 실시예에 이용한 닭고기는 대구 반야월 대형마트에서 위생적으로 처리된 생닭을 구입하여 다리, 가슴부위를 각각 150g 씩으로 나누어 준비하였다. 튀김옷은 상기 실시예 6에서 제조한 튀김가루를 사용하여 튀김가루중량의 31%의 물을 가 하여 가볍게 저어 제조한 후 튀김기름(옥수수기름)온도 180±5℃에서 10분간 1차 튀김을 하고, 5분 뒤에 180±5℃에서 2분간 2차 튀김을 하여 닭고기를 제조하고 냉각하였다.The chicken used in the present Example was prepared by dividing the leg and the breast by 150g each by purchasing hygienically treated raw chicken from Daegu Banyawol hypermarket. The frying cloth was prepared by stirring lightly by adding water of 31% of the weight of the frying powder using the frying powder prepared in Example 6, and then frying the frying oil (corn oil) temperature at 180 ± 5 ° C. for 10 minutes, After 5 minutes, a second frying at 180 ± 5 ° C. for 2 minutes to prepare chicken and cool.
대조군은 상기의 튀김가루 배합표에서 결명자 혼합추출물 분말을 제외한 배합으로 하여 상기와 같은 조건으로 닭고기 튀김을 제조하고 냉각하였다.The control group was prepared by cooling the fried chicken under the same conditions as in the formulation of the frying powder combination extract except for the deficiency mixture extract powder.
실시예 8 : 결명자 혼합 추출물 함유 튀김용 조성물로 제조된 튀김 닭의 품질 평가 Example 8 Evaluation of Quality of Fried Chicken Prepared with a Composition for Frying Mixtures
상기 실시예 7에서 제조한 튀김 닭에 대한 저장안정성, 색상 및 관능검사를 실시하고, 관능검사를 제외한 모든 실험은 3반복으로 행하여 평균값±표준편차로 나타내었으며, 관능검사 결과는 관능요원 25명이 평가한 평균값±표준편차로 나타내었다. 유의성은 SPSS-프로그램의 던컨 다중범위 시험에 의하여 검증하였다.Storage stability, color and sensory test of the fried chicken prepared in Example 7 was carried out, and all experiments except the sensory test were performed in 3 repetitions, and the mean ± standard deviation was evaluated. The mean value ± standard deviation is shown. Significance was verified by the Duncan multirange test of the SPSS-program.
1) 저장안정성1) Storage stability
상기 실시예 7에서 제조된 닭튀김을 60℃에서 4주간 저장하면서 산가와 과산화물가를 측정하여 저장 중의 변화를 살펴보았다. 즉 산가는 튀김옷 시료 O.5g을 용매(ethanol : diethyl ether =1 : 2)50mL에 용해한 뒤 1% 페놀프탈레인 지시약을 가한 후 0.01N KOH에탄올(F=1.000)로 적정하면서 엷은 분홍색이 30초간 지속될 때를 종말점으로 하였다(The Korean Society of Food Science and Nutrition. Handbook of experiments in food science and nutrition. Hyoil Seoul Korea pp.203-205(2000)).The fried chicken prepared in Example 7 was stored for 4 weeks at 60 ° C., and the acid value and the peroxide value were measured to examine the change during storage. In other words, acid value is dissolved in 50 mL of a sample of fry cloth in 50 mL of solvent (ethanol: diethyl ether = 1: 2), added with 1% phenolphthalein indicator, and titrated with 0.01 N KOH ethanol (F = 1.000) and pale pink for 30 seconds. The Korean Society of Food Science and Nutrition.Handbook of experiments in food science and nutrition.Hoil Seoul Korea pp.203-205 (2000).
과산화물가는 AOCS법(AOCS. Official Method and Recommended Practices of the American Oil Chemists' Society 4th ed. Cd. 3-25. American Oil Chemists' Society, Champaign, IL, USA(1990))에 의해 측정하였으며, 튀김옷 시료 5g을 용매(aceric acid : chloroform = 3 : 2)30mL에 완전히 용해한 다음, 포화 KI용액 0.5mL를 가하여 1분간 교반 후 증류수 30mL를 가하고 1% 전분 지시약을 가하여 0.01N sodium thiosulfate(Na2S2O35H2O)용액으로 적정하였다. Peroxide value was measured by AOCS method (AOCS. Official Method and Recommended Practices of the American Oil Chemists 'Society 4th ed.Cd. 3-25. American Oil Chemists' Society, Champaign, IL, USA (1990)) Dissolve 5 g in 30 mL of solvent (aceric acid: chloroform = 3: 2), add 0.5 mL of saturated KI solution, stir for 1 min, add 30 mL of distilled water, and add 1% starch indicator to titrate with 0.01 N sodium thiosulfate (Na2S2O35H2O) solution. It was.
산가는 유지의 산패척도를 나타내는 지표로서 식품위생법상 1.00이하이다. 튀기는 중에도 산화가 진행되는 것으로 보이며, 대조군의 경우 저장 7일째 산가가 0.92, 저장 14일째 1.19였으며, 3% 혼합 추출물 함유 튀김가루군의 경우 저장 21일째 0.74, 저장 28일째 1.01이었다.The acid value is an indicator of the scale of rancidity of fats and oils and is less than 1.00 under the Food Sanitation Law. During the frying, oxidation appeared to proceed, and the control group had an acid value of 0.92 on the 7th day of storage, and 1.19 on the 14th day of storage, and fry on the 21st day of storage of 0.74 and 1.01 on the 28th day of storage of 3% mixed extract.
과산화물가 역시 유지의 초기산패를 나타내는 지표로 이용되며, 식물성 유지는 60-100 meq/kg, 동물성 유지는 20-400 meq/kg에 도달되는 시기를 산패발생시기로 보고 그 시기까지의 저장기간을 유도기간으로 정하고 있다. 본 발명의 경우 대조군은 저장 21일째에 과산화물가가 48.184 meq/kg, 저장28일째에는 65.732 meq/kg이었으며, 3% 혼합 추출물 함유 튀김가루군은 저장 28일째에도 과산화물가가 39.211로 나타났다. Peroxide is also used as an indicator of the initial fat and loss of fats and oils, and when the fats and oils reach 60-100 meq / kg and animal fats reach 20-400 meq / kg, the storage period is induced. It is decided by period. In the case of the present invention, the control group had a peroxide value of 48.184 meq / kg at 21 days of storage and 65.732 meq / kg at 28 days of storage, and the fried powder group containing 3% mixed extract showed 39.211 even at 28 days of storage.
<표 12>TABLE 12
산가(mg KOH/g)Acid value (mg KOH / g)
1)표 11에서 결명자 혼합추출물을 제외한 조성,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) The composition without the deficiency mixture extract in Table 11, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
<표 13> TABLE 13
과산화물가(meq/kg)Peroxide value (meq / kg)
1)표 11에서 결명자 혼합추출물을 제외한 조성,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) The composition without the deficiency mixture extract in Table 11, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
2) 색상2) color
튀김 닭의 색상은 로비본드(Lovibond) 비색계(Auto Lovibond Tintometer, England)를 이용하여 색상을 측정한 후 로비본드 스케일(Lovibond sacle)에 의한 황색(Y), 적색(R)의 값을 일본기준유지분석법 2.3.16-71(本油化學協會, 基準油脂分析試驗法. (1984))에 따라 나타내었다.The color of fried chicken was measured using a Lovibond Auto Lovibond Tintometer (England), and the yellow (Y) and red (R) values were maintained by the Lovibond sacle. It was shown according to Analytical Method 2.3.16-71 (base station method, 1984).
튀김 저장 중의 색상의 변화는 표 14에 나타내었다. 시료의 저장 초기색도는 혼합 추출물의 영향으로 3% 혼합추출물 함유 튀김가루군의 황색도와 적색도가 대조군에 비해 높게 나타났다. 이후 저장기간 7일 째에는 대조군의 황색도와 적색도가 3% 혼합추출물 함유 튀김가루군에 비해 높았으나 유의적인 차이는 없었으나, 저장 14일 째부터는 대조군의 황색도와 적색도가 유의적으로 높게 나타나서 저장기간이 경과할수록 대조군의 튀김색상이 더 짙은 갈색을 띄는 것으로 나타났다. The change in color during the frying storage is shown in Table 14. The yellowness and redness of the fried powder group containing 3% mixed extract were higher than those of the control group. After 7 days of storage, the yellowness and redness of the control group were higher than those of the fried powder group containing 3% mixed extract, but there was no significant difference, but from the 14th day of storage, the yellowness and redness of the control group were significantly higher. As time passed, the fried color of the control group was darker brown.
<표 14>TABLE 14
색상(황색도, Y/적색도, R)Color (Yellow, Y / Red, R)
1)표 11에서 결명자 혼합추출물을 제외한 조성,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) The composition without the deficiency mixture extract in Table 11, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
3) 관능검사3) Sensory test
2차 튀김 후 2시간 동안 실온에서 방치한 튀김 닭을 훈련된 25명의 관능요원에 의하여 풍미, 불쾌취, 바삭한 정도, 색상 기호도, 및 종합적인 기호도에 대하여 5점 척도법으로 매우 좋다(5점), 좋다(4점), 보통(3점), 나쁘다(2점), 매우 나쁘다(1점)로 평가하였다.The fried chicken, which was left at room temperature for 2 hours after the second frying, was very good on a five-point scale for flavor, unpleasantness, crispyness, color taste, and overall taste by trained 25 sensory personnel (5 points), It evaluated as good (4 points), normal (3 points), bad (2 points), and very bad (1 point).
튀김의 관능적 특성은 표 15에 나타내었다. 그 결과 3% 혼합추출물 함유 튀김가루 군이 대조군에 비해 풍미와 바삭한 정도가 양호한 것으로 평가되었으며, 종합적인 기호도는 대조군이 평점 3.9, 3% 혼합추출물 함유 튀김 가루 군이 평점 4.2로 평가되어 기호도가 3% 혼합추출물 함유 튀김가루 군이 높게 나타났다.Sensory properties of the fries are shown in Table 15. As a result, the fried powder group containing 3% mixed extract was evaluated to have better flavor and crispness than the control group, and the overall acceptability was evaluated by the control group with a rating of 3.9 and the 3% mixed extract fried powder group with a rating of 4.2. The frying powder group containing% mixed extract was high.
<표 15>TABLE 15
관능적 특성Sensory characteristics
1)표 11에서 결명자 혼합추출물을 제외한 조성,2)Mean Duncan's multiple range test for samples(significantly p〈0.05). 1) The composition without the deficiency mixture extract in Table 11, 2) Mean Duncan's multiple range test for samples (significantly p <0.05).
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080055733A KR100937186B1 (en) | 2008-06-13 | 2008-06-13 | Composition for the fried food containing Cassia Tora L. mixed extracts and method for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080055733A KR100937186B1 (en) | 2008-06-13 | 2008-06-13 | Composition for the fried food containing Cassia Tora L. mixed extracts and method for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090129686A true KR20090129686A (en) | 2009-12-17 |
KR100937186B1 KR100937186B1 (en) | 2010-01-20 |
Family
ID=41689587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080055733A KR100937186B1 (en) | 2008-06-13 | 2008-06-13 | Composition for the fried food containing Cassia Tora L. mixed extracts and method for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100937186B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103622094A (en) * | 2013-10-31 | 2014-03-12 | 五河童师傅食品有限公司 | Day lily-cordyceps sinensis chicken soup |
KR101503429B1 (en) * | 2013-05-23 | 2015-03-18 | 한국식품연구원 | Preparation method of cassia tora l. with improved antioxidant activity by using roasting |
KR102200991B1 (en) * | 2020-08-12 | 2021-01-12 | 소병삼 | Method of manufacturing croquettes in which the aging process is omitted |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900002713A (en) * | 1988-08-05 | 1990-03-23 | 김학권 | Manufacturing method of nosebleed tea using herbal medicine and grains |
JP2000000073A (en) | 1998-06-15 | 2000-01-07 | Showa Sangyo Co Ltd | Batter for fried food and production of fried food using the same |
KR20040052987A (en) * | 2004-05-24 | 2004-06-23 | 주식회사 신우프랜차이즈 | Powder for fried chicken |
KR100838250B1 (en) | 2007-05-17 | 2008-06-23 | (주)엔돌핀에프앤비 | Method for development of tea bag using corn and corn silk |
-
2008
- 2008-06-13 KR KR1020080055733A patent/KR100937186B1/en active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101503429B1 (en) * | 2013-05-23 | 2015-03-18 | 한국식품연구원 | Preparation method of cassia tora l. with improved antioxidant activity by using roasting |
CN103622094A (en) * | 2013-10-31 | 2014-03-12 | 五河童师傅食品有限公司 | Day lily-cordyceps sinensis chicken soup |
KR102200991B1 (en) * | 2020-08-12 | 2021-01-12 | 소병삼 | Method of manufacturing croquettes in which the aging process is omitted |
Also Published As
Publication number | Publication date |
---|---|
KR100937186B1 (en) | 2010-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2006014028A1 (en) | Sweet potato stem and leaf extract and use thereof | |
KR100773809B1 (en) | Process for manufacturing red ginseng korean cookie using white ginseng and red ginseng extraction liquid | |
JP4358957B2 (en) | Agent for scavenging or reducing free radicals or active oxygen | |
CN106256258A (en) | Sesame paste | |
KR102134615B1 (en) | Manufacturing method of chicken and chicken using the same | |
KR102404589B1 (en) | Manufacturing method of Nurungi using liquerfied Opuntia humifusa | |
CN117441810A (en) | Mat bamboo and preparation method and application thereof | |
KR101030035B1 (en) | Riceyeotgangjung Containing Spirulina and preparation method thereof | |
KR100937186B1 (en) | Composition for the fried food containing Cassia Tora L. mixed extracts and method for preparing the same | |
KR100415062B1 (en) | Manufacturing method of yellow earth garlic pill | |
CN106213413A (en) | Sesame peanut paste | |
CN106213412A (en) | Peanut and walnut beans | |
CN106213414A (en) | Bean taste peanut butter | |
CN105410660A (en) | Non-fried pumpkin-taro instant noodle | |
RU2234224C2 (en) | Dry food mixture "talgan" | |
KR101838061B1 (en) | Method for producing sauce for rice | |
KR100237974B1 (en) | Confectionery composition containing principally the bark of mulberry tree for diabetic | |
KR101011241B1 (en) | Cassia Tora L. mixed extracts and method for preparing the same | |
KR20150111786A (en) | Manufacturing method for Sunsik using Jeungpo (steamed and dried) method and Sunsik prepared by the method | |
KR102323687B1 (en) | A manufacturing method of Paste containing Ginkgo nuts and Bellflower Root Extract | |
KR20180093209A (en) | Hot unpolished rice manufacture method containing extracts of Hericium erinacium | |
KR20090032641A (en) | A method for deorderizing galics, seasonings and processed foods made by the method | |
KR20170062936A (en) | Preparing method for sunsik | |
JP5300013B2 (en) | 柿 Fruit fraction and its use | |
KR101677478B1 (en) | Method for producing black rice chocolate with improved antioxidant activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121122 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131025 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20141024 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160108 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181206 Year of fee payment: 10 |